YT-CB5, which had been continuously cultured with chrysotile B (CB) asbestos, showed impaired cytotoxicity with decreased expression of NKG2D and 2B4 NK cell-activating receptors. In the present study, the phosphorylation of extracellular signal-regulated kinase (ERK), which is known to induce degranulation downstream of many NK cell-activating receptors, was examined in YT-CB5 by flow cytometry and compared with the control line YT-Org. YT-CB5 exhibited impaired phosphorylation of ERK1I2 induced by the recognition of K562 cells, downstream of a process mediated by Src family kinase and phosphoinositide 3-kinase. YT-CB5 also exhibited impaired phosphorylation of ERK1I2 following incubation with K562 cells in the presence of anti-2B4 antibodies, where co-stimulation by 2B4 augmented the phosphorylation of ERK1I2 in YT-CB5 to a similar degree as in YT-Org. The phosphorylation ofERK1I2 induced by an inhibitor against phosphatase (PP) 1 and PP2A was also lower in YT-CB5 compared with YT-Org. Moreover, bead-bound antibodies to NKG2D, which contribute to cytotoxicity against K562 cells, induced negligible phosphorylation of ERK1I2 in YT-CB5, although antibodies to 2B4. induced a comparatively greater level of phosphorylation. Additionally, peripheral blood (PB-) NK cells with low expression ofNKG2D showed lower phosphorylation ofERK1I2 mediated by anti-NKG2D antibodies compared with PB-NK cells with high expression of NKG2D. These results indicate that signal transduction events leading to the phosphorylation of ERK is impaired in YT-CB5 due to decreased expression ofNKG2D. Further studies are required to clarify whether this suppressive effect of asbestos exposure on NK cells might promote lung cancer and mesothelioma in people who have inhaled asbestos.
It is well-known that asbestos leads to diseases such as malignant mesothelioma (MM) and lung cancer (1) . It is commonly believed that the cause of tumor diseases induced by inhaled asbestos might be due to its tumorigenic activity. Previous reports have detailed the oxidization of nucleotide bases and increases in mutation frequencies induced by asbestos (2) (3) . However, the long incubation period observed prior to the development of malignant mesothelioma suggests effects other than tumorigenicity associated with asbestos exposure.
Based on this hypothesis, we examined and demonstrated the effect of asbestos exposure on human immune competent cells (4) (5) (6) (7) . In particular, we recently demonstrated that continuous exposure to asbestos impaired the cytotoxicity of the human Natural killer (NK) cell line and observed decreased expression levels of NKG2D and 2B4 NK cellactivating receptors (6) . The cytotoxicity of NK cells against targets of transformed or virus-infected cells is controlled by various types of NK cellactivating and inhibitory receptors. These receptors include NKG2 family members, natural cytotoxicity receptors (NCRs), and the signaling lymphocytic activation molecule (SLAM) family of receptors (8) (9) . NKG2D is a representative activating receptor involved with NKG2 family members. It forms a homodimer and can transduce intracellular signals to induce degranulation via the adaptor molecule DAPIO (8, (10) (11) . 2B4 (CD244) is a representative SLAM family receptor expressed on NK cells and can activate NK cells to exert cytotoxicity (12) (13) (14) . NCRs, including NKp46, NKp44 and NKp30, also playa major role in the NK-mediated death of most tumor cell lines (10, 15) .
In our recent study, the asbestos-exposed human NK cell line YT-CB5 showed decreased expression levels of cell-surface NKG2D and 2B4 compared with the control cell line YT-Org (6) . In an effort to explore the relation between decreased expression of NKG2D and 2B4 and impaired cytotoxicity, we examined degranulation following stimulation of YT-CB5 with antibodies to NKG2D and 2B4. It was demonstrated that degranulation induced via NKG2D and 2B4 was impaired and partially impaired, respectively, in YT-CB5 cells concurrently with decreased cytotoxicity.
However, NK cell-activating receptors are not directly linked to the induction of degranulation, but utilize intracellular molecules to transduce the activation signal. Although NK cell-activating receptors possess different adaptor molecules, most of the receptors finally utilize common molecules to induce degranulation, one of which is extracellular signal-regulated kinase (ERK) (16) . It has been shown that ERK is essential for the polarization of cytotoxic granules to the immunological synapse, the area in contact with target cells (17) . Thus, to clarify the relation between decreased NKG2D and 2B4 on the cell-surface and impaired cytotoxicity in YT-CB5, it would be useful to examine the level of phosphorylated ERK following ligand binding.
Therefore, in the present study, we examined the phosphorylation of ERK in YT-CB5 following stimulation with target cells and antibodies to several NK cell-activating receptors, and compared the findings with results for YT-Org.
MATERIALS AND METHODS

Cells and culture
Cells were cultured in RPMII640 medium supplemented with 10% fetal bovine serum (FBS) and antibiotics. The human NK cell line YT-AI was a gift from Prof Y. Yodoi. Cultures continuously exposed to asbestos were prepared as previously described (6) . Cells were cultured with chrysotile B (CB) asbestos at 0 or 5 ug/ml in culture flasks for more than 5 months and referred to as YT-Org and YT-CB5, respectively. Cells were then separated from CB using a Ficoll-Hypaque density gradient (Separate-L®, Muto Pure Chemicals Co. Ltd., Tokyo, Japan) prior to being used for the functional assays.
Measurement ofcytotoxicity
Cytotoxicity against target cells was performed using flow cytometry as previously described (6) . K562 cells were stained using Vybrant" Dio Cell-Labeling Solution (Invitrogen, Carlsbad, CA). After washing with PBS, YT-Org, YT-CB5 or purified peripheral blood NK cells were incubated with 5000 Dio-labeled K562 cells at several different E/T ratios for 5 h. Following incubation, cells were collected and stained using PI, and then analyzed for the percentage of Pl" Dio-labeled cells among the total number of Dio-labeled cells using FACScalibur™ (Becton Dickinson, Franklin Lakes, NJ). The percentage of specific lysis induced by effector cells was calculated as follows: (percentage of lysed cells -percentage of spontaneously dead cells)/(100 -percentage of spontaneously dead cells) x 100, where percentage of spontaneously dead cells represented the percentage of dead cells in target cells harvested from wells in the absence of effector cells.
Assay for expression levels ofcell-surface molecules
To examine the expression levels of molecules on the cell surface, YT-Org and YT-CB5 cells were stained using PE-labeled antibodies against NKG2D (eBioscience, San Diego, CA) or 2B4 (Becton Dickinson). Purified peripheral blood NK cells were stained using PE-labeled anti-NKG2D, 2B4 or NKp46 antibody (Beckman Coulter, Inc., Fullerton, CA) The mean fluorescence intensity was measured and analyzed using flow cytometry.
Assay for phosphorylated ERK
The phosphorylation of ERK was assayed using flow cytometry, an approach utilized by another study (16) . 2 x 10 5 YT-Org or YT-CB5 cells were mixed with 5 x 10 4 K562 cells in the culture medium, spun down, and incubated at 3TC in 5% CO 2 , For a part of the experiments involving incubation with K562 cells, 250 IlM wortmannin and 20 IlM PP2, which act as inhibitors against phosphoinositide 3-kinase (PI3K) and Src-family kinase (SFK) (EMD Chemicals Inc, Darmstadt, Germany), respectively, were each added to the medium. For another part of experiments, YT-Org or YT-CB5 cells were treated with control Ig or anti-2B4 antibodies (Beckman Coulter) at room temperature for 20 min prior to incubation with K562 cells. Cells were also incubated with calyculin A, an inhibitor against phosphatase (PP) I and PP2A, to examine the phosphorylation of ERK independently of NK cell-activating receptors. After 30 min incubation, or the period of time as indicated in the figure, cells were fixed using 2% paraformaldehyde at 3TC for 10 min. Cells were washed with cold PBS containing 2% FBS and then permeabilized using ice-cold 90% methanol on ice for 30 min. After washing with 2%-FBS-PBS, cells were stained using PE-Iabeled antibodies to phospho-ERKl/2, clone 20A (Becton Dickinson), at room temperature for 2 h. Cells were washed with 2%-FBS-PBS and assayed for the percentage of phospho-ERKl/2-positive cells by flow cytometry. In other experiments, cells were stimulated with bead-bound antibodies and assayed for the phosphorylation of ERK. Anti-NKG2D, anti-2B4 murine antibodies, and a combination of anti-NKG2D/ NKp46 murine antibodies (Becton Dickinson) were each incubated with anti-mouse-IgG-coated beads (Spherotec, Inc., Lake Forest, IL) at room temperature for 30 min. After the beads were washed with PBS, 5 x 10 4 cells were incubated with 2 x 10 5 beads in a FACS tube, fixed and permeabilized as described above, and then assayed for the percentage of phospho-ERKl/2-positive cells by flow cytometry. Purified peripheral blood NK cells were also stimulated with bead-bound antibodies, and assayed for the phosphorylation of ERK in the same manner as described above. To remove background levels of phospho-ERK, the percentage ofphospho-ERK in PB-NK cells incubated with bead-bound control Ig was subtracted from the percentage obtained in PB-NK cells incubated with antibodies to NKG2D, NKp46 or 2B4.
Preparation of PBMes and purification of peripheral blood NK cells
PBMCs were isolated from heparinized blood of healthy volunteers using a Ficoll-Hypaque density gradient. Peripheral blood NK cells not labeled with antibodies were purified from PBMCs by magnetic cell sorting using the NK Cell Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Purified NK cells were assayed for cytotoxicity, expression ofNK cell-activating receptors and the phosphorylation of ERK. Specimens were taken from healthy volunteers from whom informed consent had been obtained. The project was approved by The Institutional Ethics Committee of Kawasaki Medical School.
Statistical analysis
The significance of differences was determined using ANOVA with the post hoc test of Student-Newman-Keuls. The statistical analysis was performed using StatView 5.0J (SAS Institute, Cary, NC) in accordance with Statistical Principles in Experimental Design (18) .
RESULTS
Phosphorylation of ERK1I2 in YT-CB5 following incubation with K562 cells
YT-CB5 is the subline which had been continuously cultured with exposure to asbestos, and showed impaired cytotoxicity against K562 cells compared with the control subline YT-Org (Fig.  IA) . The cytotoxicity against K562 cells is known to be dependent on NKG2D (16) . YT-CB5 showed decreased expression of cell-surface NKG2D and 2B4 ( Fig IB) . The phosphorylation of ERKl/2 in YT-CB5 and YT-Org was examined following incubation with K562 cells. YT-Org .exhibited a time-dependent increase in the percentage of cells with phospho-ERKl/2 ( Fig. Ie) . However, YT-CB5 exhibited a markedly lower level of phosphorylated ERKl/2 following incubation with K562 cells, with a significant difference between YT-Org and YT-CB5 being evident at 30 min post-incubation ( Fig 1C, D) . These results indicate that the phosphorylation of ERK induced by the recognition of K562 cells is impaired in YT-CB5.
Analysis ofERK1I2-phosphorylation induced by the recognition ofK562 cells using kinase inhibitors
Stimulation with NKG2D leads to the phosphorylation of ERK downstream of a process mediated by SFK and PI3K, and which could be inhibited by PP2 and wortmannin, respectively (16) . Therefore, the phosphorylation of ERK in YT-Org and YT-CB5 was examined following incubation with K562 cells in the presence of each inhibitor (Fig. 2) . Both PP2 and wortmann in inhibited the increase in phosphorylation levels ofERKl/2 in YT-Org following incubation with K562 cells. Although the level of phosphorylated ERKI/2 in YT-CB5 was low, it was also inhibited by PP2 and wortmannin, where the phosphorylation level was representative of the background level in both YT-Org and YT-CB5. These results indicate that YT-CB5 possesses impaired phosphorylation of ERK downstream of a process mediated by SFK and PI3K following the recognition of target cells.
Phosphorylation ofERKI/2following co-stimulation with anti-2B4 antibodies K562 cells are known to be target cells which do not possess CD48, a known ligand of 2B4, and the cytotoxicity of NK cells against K562 cells is not inhibited by antibodies to 2B4 (16) . Additionally, it has been reported that concomitant 2B4-mediated stimulation augmented the cytotoxicity of NK cells (19) . Therefore, YT-Org and YT-CB5 were treated with anti-2B4 antibodies prior to incubation with K562 cells, and assayed for phosphorylation levels of ERKlI2 (Fig. 3 ). Co-stimulation with anti-2B4 antibodies significantly augmented the level of phosphorylated ERKlI2 in YT-Org following incubation with K562 cells. YT-CB5 exhibited significantly lower phosphorylation levels of ERKlI2 compared with YT-Org, even following co-stimulation with anti-2B4 antibodies. However, 2B4-mediated co-stimulation also significantly augmented the phosphorylation of ERKlI2 in YT-CB5. These results suggest that 2B4-mediated signal transduction leading to the phosphorylation of ERK might be unimpaired in YT-CB5, whereas the phosphorylation of ERK induced by the recognition of K562 cells was impaired.
Phosphorylation of ERKJl2 induced by the PPJl2A inhibitor calyculin A
The results described above show that impaired phosphorylation of ERK is related to altered expression of NK cell-activating receptors in YT-CB5. Receptor-independent phosphorylation of ERK induced by the PP lI2A inhibitor calyculin A was then examined (Fig. 4) . Calyculin A can induce the phosphorylation of ERK by inhibiting PPlI2A, which prevent MAPKIERK kinase (MEK)mediated phosphorylation of ERK. Treatment with calyculin A induced the phosphorylation of ERKlI2 at high dose (100 nM) but did not at low dose (25 
Anti-NKG2D and 2B4 antibody-dependent phosphorylation ofERKI/2
Finally,to clarify the effectsofdecreased expression of NKG2D and 2B4 in YT-CB5 on downstream intracellular signal transduction, NKG2D-and 2B4dependent induction of phospho-ERK was examined using antibodies to NKG2D and 2B4 (Fig. 5) . Additionally,since NKp46 is known to contribute to the cytotoxicity of NK cells against K562 cells (15) , anti-NKp46 antibodies were also used in combination with anti-NKG2D antibodies. YT-Org and YT-CB5 were incubated with beads pre-treated with anti-NKG2D, anti-2B4 or a combination of anti-NKG2D and anti-NKp46 antibodies. YT-Org exhibited increased phosphorylation of ERKl/2 following incubation with bead-bound antibodies to NKG2D (Fig. 5) . In contrast, YT-CB5 induced only slight phosphorylation ofERKl/ 2 following stimulation with bead-bound antibodies to NKG2D. Combination treatment with anti-NKp46 antibodies augmented the phosphorylation of ERKl/2 induced by anti-NKG2D antibodies in both YT-Org and YT-CB5. However, YT-CB5 also exhibited a significantly lower level of phospho-ERKl/2 even following stimulation with combined anti-NKG2D and anti-NKp46 antibodies compared with YT-Org. Stimulation with bead-bound antibodies to 2B4 the aforementioned receptors (B, D) and cytotoxicity against K562 cells (E, F), by flow cytometry. Dotted lines in A represent not-stained control. The region of cells showing phosphorylated ERK is defined by the marker. C) Expression levels of NKG2D, NKp46 and 2B4 are expressedas meanfluorescence intensity (MF!). The columns in each histogram were sorted according to the MF! order. The numbers below the horizontal axis show the serial number ofeach individual healthy volunteer. D) PB-NK cells were incubated with beads pre-treated with anti-NKG2D, anti-NKp46 or anti-2B4 antibodies. Following incubation with the beads, cells were assayedfor phosphorylated ERK!/2 by flow cytometry. The order of the columns in the histogram is the same as that for each corresponding histogram shown in C. E, F) Cytotoxicity against K562 cells was assayed byflow cytometry. The histogram of% specific lysis at 2 ofthe EfTratio is shown in E, where the order ofthe columns is the same as that for the histogram of NKG2D MF!. Whole data relating to cytotoxicity are shown in F. Data represent the mean ± SD from three wells at each E/T ratio.
Fig. 6. Analysis for expression levels of NK cellactivating receptors and the phosphorylation of ERK in peripheral blood NK cells. Peripheral blood (PB-) NK cells from eight individuals were examined for expression levels of NKG2D, NKp46 and 2B4 (A, C), phosphorylation level ofERKfollowing stimulation via
EfT ratio 
Comparison of ERKl/2-phosphorylation between peripheral blood NK cells with high and low expressions ofNKG2D
YT-CB5 exhibited impaired NKG2D-mediated phosphorylation of ERKl/2 in addition to decreased NKG2D expression levels and cytotoxicity.To confirm the relation between NKG2D expression levels and the phosphorylation of ERK, peripheral blood (PB-) NK cells from eight healthy volunteers were examined (Fig. 6 ). PB-NK cells exhibited a gradual decrease in DISCUSSION YT-CB5 is a subline of the human NK cell line continuously exposed to asbestos. In our last study, we demonstrated that YT-CB5 possesses impaired cytotoxicity and decreased expression of NKG2D and 2B4 compared with the control line YT-Org (6) . In the present study, the phosphorylation of ERK following stimulation with target cells and antibodies to several NK cell-activating receptors was examined in an effort to clarify the relation between decreased expression of cell-surface NKG2D and 2B4 and impaired cytotoxicity in YT-CB5. ERK is commonly phosphorylated downstream to most NK cell-activating receptors including NKG2D, 2B4 and NKp46 (16) . YT-CB5 exhibited impaired phosphorylation of ERK induced by the recognition of K562 cells downstream of a process mediated by SFK and PI3K. Stimulation with bead-bound antibodies to NKG2D also induced little phosphorylation of ERK in YT-CB5. In contrast, co-stimulation with anti-2B4 antibodies augmented the phosphorylation of ERK in YT-CB5 following incubation with K562 cells, and stimulation with bead-bound antibodies to 2B4 also induced marked phosphorylation ofERK in YT-CB5. These results indicate that decreased expression of NKG2D results in insufficient intracellular signal transduction in YT-CB5, unlike the case associated with decreased expression of 2B4 which had little effect. These findings are consistent with our previous investigations concerning degranulation, where bead-bound antibodies to NKG2D could not induce degranulation in YT-CB5, whereas beadbound antibodies to 2B4 could induce degranulation (6) . Therefore, it is probable that insufficient signal transduction following decreased expression of NKG2D may lead to impaired degranulation, thereby resulting in low cytotoxicity in YT-CB5.
To confirm the relation between NKG2D expression levels and the phosphorylation of ERK, PB-NK cells from eight healthy volunteers were examined. PB-NK cells showed decreased phosphorylation of ERK following stimulation via NKG2D and NKp46 as NKG2D and NKp46 expression levels became low. PB-NK cells from two individuals showed markedly high phosphorylation of ERK following stimulation via NKG2D, even though they possessed mid-level expression of cellsurface NKG2D. This finding suggests that some factors other than the expression level of NKG2D might contribute to the phosphorylation level of ERK following stimulation via NKG2D. However, although the results included those of exceptional cases, they indicate that there is a difference in the phosphorylation level of ERK in cells following stimulation via NKG2D among individuals in relation to the expression level of NKG2D, and that PB-NK cells having low expression levels of NKG2D show low phosphorylation levels of ERK following stimulation via NKG2D and low cytotoxicity against K562 cells. Therefore, these findings support the idea that decreased expression of cell-surface NKG2D in YT-CB5 causes insufficient intracellular signal transduction, thereby resulting in impaired cytotoxicity. Additionally, the findings indicating that there was no relation between the phosphorylation of ERK following stimulation via 2B4 and the expression level of 2B4 are consistent with the results concerning YT-CB5 in our present and previous studies, in which there was no decrease in the phosphorylation of ERK or degranulation following stimulation with bead-bound antibodies to 2B4 (6) .
In addition to the impaired phosphorylation of ERK induced by stimulation with NKG2D, YT-CB5 exhibited decreased phosphorylation of ERK following treatment with 50 nM calyculin A. Calyculin A is an inhibitor ofPPl and PP2A, which prevent MEK-mediated phosphorylation of ERK. These results suggest that YT-CB5 might possess an imbalance related to the phosphorylation and dephosphorylation ofERK. However, treatment with 100 nM calyculin A could induce the phosphorylation of ERK in YT-CB5 to the same level as found in YT-Org. Therefore, the possible imbalance between phosphorylation and dephosphorylation which exists in YT-CB might be limited.
Thus, taken together with findings of the previous study, our investigations demonstrate that continuous exposure to asbestos has the potential to cause altered expression of NK cell-activating receptors, which leads to impaired cytotoxicity ofNK cells as mediated by decreased phosphorylation of ERK downstream of NK cell-activating receptors. It is possible that impaired cytotoxicity of NK cells may exert harmful effects on anti-tumor immunity at both the innate and acquired immunity levels since NK cells are known to interact with dendritic and helper T cells (20) (21) (22) (23) . This suppressive effect of asbestos exposure on the cytotoxicity of NK cells might contribute to the development and progress of malignant tumor in people who have inhaled asbestos. Further studies are required to clarify this issue.
